Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 181 publications
Molecular subtypes of stage III vulvar squamous cell carcinoma predict recurrence and survival outcomes.
Journal: Gynecologic oncology reports
Published: June 19, 2026
Predicting residual disease and extent of surgery after neoadjuvant chemotherapy for ovarian cancer: Does the MSKCC model from the primary setting apply?
Journal: Gynecologic oncology
Published: June 19, 2026
Secondary cytoreduction for ovarian cancer relapse: results from the high surgical quality, multi-center "Surgery in Recurrent Ovarian Cancer Research Consortium (SURROC-CON)".
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 07, 2026
Prehabilitation during neoadjuvant chemotherapy in advanced ovarian cancer is associated with improved surgical candidacy and chemotherapy outcomes.
Journal: Gynecologic oncology
Published: May 05, 2026
Long-Term Survival in High-Grade Serous Ovarian Cancer Compared With the General US Population: A 30-Year Landmark Analysis.
Journal: JCO oncology advances
Published: April 01, 2026
Recent national trends in pelvic and paraaortic lymphadenectomy in gynecologic oncology fellowship training programs: ACGME data from 2019-2025.
Journal: Gynecologic oncology reports
Published: March 18, 2026
Innovation through standardization: Reducing the ileostomy rates while targeting zero anastomotic leaks at cytoreductive surgery.
Journal: Gynecologic oncology
Published: March 08, 2026
National Trends in Radical Hysterectomy at Gynecologic Oncology Fellowship Training Programs.
Journal: O&G open
Published: February 28, 2026
Lymphadenectomy in early-stage ovarian cancer: is there still a role?
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: November 10, 2025
Lymphadenectomy in early-stage ovarian cancer: is there still a role?
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: November 10, 2025
The progesterone paradigm: Molecular prognostication in conservative management of endometrial cancer.
Journal: Gynecologic oncology
Published: November 02, 2025
MECOM amplified endometrial cancer, a novel subset of copy number high tumors associated with poor prognosis.
Journal: Gynecologic oncology reports
Published: October 01, 2025
Last Updated: 09/26/2026